Metsera, Inc. MTSR
Set alert
70.50 USD 0.00 0.00%
At close · Nov 13
70.13 Day range 70.76
51.92 52-week range 83.86
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 70.74
- Prev close
- 70.50
- Mkt cap
- 7.43B
- Vol
- 27.87M
- Avg vol
- 4.84M
- EPS
- -6.32
- P/E
- -39.83
- Div yield
- 0.00%
More statistics
- Low
- 70.13
- High
- 70.76
- Beta
- 1.70
- Inst. own
- 90.24%
- Dividend
- 0.00
- Earnings
- Mar 25, 2026
Discussion (1)
Sign in to join the discussion
VICKY HANUKA MTSR 1 year ago #1Obesity drug developer Metsera sets terms for $275M IPO
Val Brickates Kennedy
Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.
2d illustrations and photos/iStock via Getty Images
Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering.
In a recent SEC filing, Metsera (MTSR) said it was looking to offer 17.2M shares priced between $15
Symbol Last Price % Chg
MTSR - -
Metsera, Inc.